Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8937118 | 1.00 | MPI (0.35) | MPI | |
| Lactic Acid SCHEMBL2582472 | 0.95 | TP53 (0.37) | MPI | |
| Glycerin SCHEMBL9351848 | 0.92 | MPI (0.31) | MPI | |
| Succinic Acid SCHEMBL4315810 | 0.92 | MPI (0.31) | MPI | |
| SCHEMBL424017 | 0.89 | MPI (0.35) | MPI | |
| SCHEMBL215097 | 0.83 | MPI (0.36) | MPI | |
| SCHEMBL2884877 | 0.83 | MPI (0.36) | MPI | |
| SCHEMBL426315 | 0.83 | MPI (0.36) | MPI | |
| SCHEMBL13430949 | 0.83 | MPI (0.36) | MPI | |
| SCHEMBL8367251 | 0.83 | MPI (0.32) | MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504890-A1 | ARTIFICIAL LYMPH NODE BIOREATOR | Mirror Biologics, Inc. (US) | 2025-02-12 | — | — | EP | claimed |
| CN-114487168-B | Preparation and value setting method of blood lactic acid standard substance | 中国计量科学研究院 | 2024-03-12 | — | — | CN | claimed |
| WO-2023196391-A1 | ARTIFICIAL LYMPH NODE BIOREATOR | MIRROR BIOLOGICS, INC. (US) | 2023-10-12 | — | — | WO | claimed |
| US-20230323264-A1 | Artificial lymph node bioreactor | MIRROR BIOLOGICS, INC. | 2023-10-12 | — | — | US | claimed |
| CN-115969762-A | Long-acting high-efficiency moisturizing supermolecule liposome mask and preparation method thereof | 深圳市萱嘉生物科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-114487168-A | Preparation and value determination method of blood lactic acid standard substance | 中国计量科学研究院 | 2022-05-13 | — | — | CN | claimed |
| US-9890356-B2 | Use of G-CSF in in vitro embryo culture | SCARPELLINI FABIO (IT) | 2018-02-13 | — | — | US | claimed |
| US-20170363565-A1 | Analyte Measurement | INSIDE BIOMETRICS INTERNATIONAL LIMITED (GB) | 2017-12-21 | — | — | US | claimed |
| US-20260125357-A1 | LACTATE ENHANCING COMPOUNDS AND USES THEREOF | GLIAPHARM SA (CH) | 2026-05-07 | — | — | US | disclosed |
| EP-4728045-A2 | MODULAR BIOREACTOR SYSTEMS FOR REGENERATIVE MEDICINE APPLICATIONS | Wake Forest University Health Sciences (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260053860-A1 | METHOD OF PROMOTING RETURN OF ESTRUS IN ANIMAL AND AGENT FOR PROMOTING RETURN TO ESTRUS IN ANIMAL | ANICOM HOLDINGS, INC. (JP) | 2026-02-26 | — | — | US | disclosed |
| US-20260041818-A1 | BIOENGINEERED INTERNAL ANAL SPHINCTER CONSTRUCTS AND METHODS OF USE THEREOF | CELLF BIO INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12533462-B2 | Infusion unit | INFUZAMED LLC | 2026-01-27 | — | — | US | disclosed |
| US-20250258125-A1 | BIOSENSOR AND MANUFACTURING METHOD THEREFOR | LEADWAY (HK) LIMITED (CN) | 2025-08-14 | — | — | US | disclosed |
| CN-1134110-A | Method for regulating gastrointestinal motility | AMYLIN PHARMACEUTICALS INC (US) | 1996-10-23 | — | — | CN | disclosed |
| WO-1996012408-A1 | REAGENTS WITH ENHANCED PERFORMANCE IN CLINICAL DIAGNOSTIC SYSTEMS | CHIRON DIAGNOSTICS CORPORATION (US) | 1996-05-02 | — | — | WO | disclosed |
| EP-0597033-A1 | IGF-1 TO IMPROVE THE NEURAL CONDITION. | GENENTECH INC (US) | 1994-05-18 | — | — | EP | disclosed |
| WO-1993002695-A1 | IGF-1 TO IMPROVE THE NEURAL CONDITION | GENENTECH, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
| EP-0052718-B1 | METHOD AND APPARATUS FOR THE DETERMINATION OF SUBSTANCES IN BIOLOGICAL SOLUTIONS BY DIFFERENTIAL PH MEASUREMENT | Luzzana, Massimo (IT) | 1985-09-11 | — | — | EP | disclosed |
| EP-0052718-A1 | Method and apparatus for the determination of substances in biological solutions by differential pH measurement | Luzzana, Massimo (IT) | 1982-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041818-A1 | BIOENGINEERED INTERNAL ANAL SPHINCTER CONSTRUCTS AND METHODS OF USE THEREOF | NES, MYH2, MYH10 | MPI 3213/4885 |
| US-12533462-B2 | Infusion unit | TNF, SEC24C, ATP6V1B1 | MPI 2522/4885 |
| US-20260125357-A1 | LACTATE ENHANCING COMPOUNDS AND USES THEREOF | LDHA, PC, LDHB | MPI 1870/4885 |
| US-20260053860-A1 | METHOD OF PROMOTING RETURN OF ESTRUS IN ANIMAL AND AGENT FOR PROMOTING RETURN TO ESTRUS IN ANIMAL | PGF, ALPP, FABP4 | MPI 4577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.